Opdivo gets ‘perioperative’ approval; pharmas cut jobs in New Jersey, Ireland
Today, a brief rundown of news from Bristol Myers Squibb and Johnson & Johnson, as well as updates from Bayer, the World Health Organization and Frazier Life Sciences that you may have missed. Bristol Myers Squibb said Thursday its cancer immunotherapy …